EVALUATION AND MEDICAL MANAGEMENT

The lifetime risk of surgical treatment of men with clinical BPH is about 30%. ... specific alpha-blockers and 5-alpha reductase inhibitors have provided a new insight for medical therapy of BPH. The risk of clinical progression to BPH was reduced by 39% with the use of alpha adrenergic receptor blocker and by about 34% with 5alpha reductase ... ................
................